What we do Rekvina Labs Ltd is an Indian pharmaceutical company specializing in manufacturing and marketing pharmaceutical formulations and providing contract research and manufacturing services. |
Founded in 1,988 |
Market share Small player with sales over Rs 20 Crore; currently facing industry recession and operational challenges. |
Problem solved Provides quality pharmaceutical products tailored to customer needs, addressing healthcare formulation demands. |
Top clients or who we serve Serves pharmaceutical customers requiring custom formulations and contract manufacturing; primarily B2B. |
Key management Mr. Amit Mukesh Shah (Managing Director) and Mr. Surbhit Shah (Executive Director & CFO) lead the company. |
Our journey and innovations Started in the 1980s, launched 'REKSEAL' tissue adhesive in 1999-2000, and focused on cost competitiveness and regulatory compliance improvements. |
Where we operate Operations primarily in India; no exports currently; registered in the UK. |
Top products or what we offer Pharmaceutical formulations and contract manufacturing services; flagship product includes 'REKSEAL' tissue adhesive. |
Top brands REKSEAL - tissue adhesive for wound closure, launched around 1999-2000. |
Raw materials needed Pharmaceutical raw materials for formulation manufacturing. |
Raw materials supplier - |
Recurring vs cyclical contribution Revenue has been cyclical with challenges due to industry recession and economic slowdown. |
Our industry position Operates in pharmaceuticals with a small market share and currently under financial strain. |
Financial highlights 2024-25 revenue was nil with a net loss of Rs 0.14 crore; earlier sales turnover over Rs 20 Crore. |
Geographical revenue split - |
Order book - |
Whats driving growth Focus on strengthening manufacturing core, R&D for cost competitiveness, and global regulatory compliance. |
Our future plans Plans to improve operations, comply with listings, and explore new growth opportunities within pharma manufacturing. |
Our green promise - |
Our people and values Emphasizes efficient resource use, strong management control, with a governance board of experienced directors. |
Key challenges ahead Industry recession, economic slowdown, non-compliance issues impacting trading and financial losses. |
Interesting facts Company was registered as a public limited company in England and Wales; launched a notable tissue adhesive product. |
Risks and strategy Risks include market recession and regulatory compliance; strategies focus on cost optimization and heightened compliance. |
